In short-term diabetic responders, glucagon produced greater C-peptide responses than glucose and tolbutamide, with a mean increase of 0.62 pmol/ml.
In plain wordsIn short-term diabetic responders, glucagon produced greater C-peptide responses than glucose and tolbutamide, with a mean increase of 0.62 pmol/ml.
- Peptide
- Glucagon
- Outcome
- IncreaseC-peptide response in short-term diabetic responders
- Study
n: not reported in source
- Comparator
- Glucose and tolbutamide provocative tests
- Outcome group
- Diagnostic Response · Endocrine and hormones
Measurements
- C-peptide increase
- 0.62 pmol/ml
- short-term responders
Source sentences
The greatest C-peptide responses occurred after glucagon administration (mean increase 0.62 pmol/ml) in short-term responders.
1 context sentence(design, population, supporting numbers)
Residual beta cell secretory capacity was assessed in short term (2 months to 2 years) and long term (5 to 8 years) insulin-dependent diabetics by measurement of serum C-peptide immunoreactivity during three provocative tests: glucose, tolbutamide, and glucagon.
In this study, Glucagon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Glucagon.